Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002;2(3):120-123.
doi: 10.1155/S1110724302203010.

Alzheimer Disease and Oxidative Stress

Alzheimer Disease and Oxidative Stress

George Perry et al. J Biomed Biotechnol. 2002.

Abstract

Research in Alzheimer disease has recently demonstrated compelling evidence on the importance of oxidative processes in its pathogenesis. Cellular changes show that oxidative stress is an event that precedes the appearance of the hallmark pathologies of the disease, neurofibrillary tangles, and senile plaques. While it is still unclear what the initial source of the oxidative stress is in Alzheimer disease, it is likely that the process is highly dependent on redox-active transition metals such as iron and copper. Further investigation into the role that oxidative stress mechanisms seem to play in the pathogenesis of Alzheimer disease may lead to novel clinical interventions.

PubMed Disclaimer

References

    1. Smith M A, Taneda S, Richey P L, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA. 1994;91(12):5710–5714. - PMC - PubMed
    1. Smith M A, Harris P.L R, Sayre L M, Beckman J S, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci. 1997;17(8):2653–2657. - PMC - PubMed
    1. Montine T J, Amarnath V, Martin M E, Strittmatter W J, Graham D G. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol. 1996;148(1):89–93. - PMC - PubMed
    1. Sayre L M, Zelasko D A, Harris P L, Perry G, Salomon R G, Smith M A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem. 1997;68(5):2092–2097. - PubMed
    1. Smith C D, Carney J M, Starke-Reed P E, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA. 1991;88(23):10540–10543. - PMC - PubMed

LinkOut - more resources